A Phase 2B, Randomized, Controlled Study of HTX-011 Administered Via Pectoral Nerve Block in Subjects Undergoing Upper Extremity Surgery for Augmentation Mammoplasty
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Bupivacaine
- Indications Anaesthesia
- Focus Therapeutic Use
- Sponsors Heron Therapeutics
- 22 Nov 2017 Planned number of patients changed from 120 to 240.
- 22 Nov 2017 Planned End Date changed from 1 Dec 2017 to 1 Apr 2018.
- 22 Nov 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Apr 2018.